Midas Pharma News Today

EQS-News: APONTIS PHARMA AG / Key word: Product Launch APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property... | April 12, 2023

EQS-News: APONTIS PHARMA AG / Key word(s): Product LaunchAPONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential 12.04.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announceme...

12.04.2023 - EQS-News: APONTIS PHARMA AG / Key word(s): Product Launch APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential 12.04.2023 / 07:30 ... Seite 1

MARKET OUTLOOK The demand for advanced and innovative solutions, such as self-administered drug delivery devices, is rising in high-income countries,...

/PRNewswire/ -- According to Ariztons latest research report, the pharmaceutical packaging market will grow at a CAGR of 4.65% from 2021-2027. Growing demand...

CHICAGO, Dec. 7, 2022 /PRNewswire/ -- According to Arizton's latest research report, the pharmaceutical packaging market will grow at a CAGR of 4.65% from 2021-2027. Growing demand for pharmaceuticals

MARKET INSIGHTS In a world of exponentially growing information, increasingly sophisticated technology, and an unstable economic environment,...

Investegate announcements from APONTIS PHARMA AG, APONTIS PHARMA expands profitable positioning in first half of 2022 – full-year forecast confirmed

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recently adopted positive opinions for three biosimilar products.

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recently adopted positive opinions for three biosimilar products. On June 23, 2022, CHMP...